Cataract-stasis and visual function series
Russian titles argue retinalamin cataract-static effects and report long-term visual function dynamics with retinalamin. Archive map of published ophthalmology series.
identity
fraction
bovine retina polypeptide fraction
Retinal cytomedin fraction. Mixture of sequences. Molecular neighbourhood shared with short pineal peptides in retinoprotection writing.
Key takeaways
- Retinalamin is a bovine retina polypeptide fraction from the Kirov Military Medical Academy / Khavinson ophthalmology neighbourhood.
- Mapped themes include cataract-stasis combination series, molecular retinoprotection shared with short peptides, circadian / desynchronosis language in glaucoma, and tear-fluid neuronal markers.
- One of the denser eye-shelf trails among secondary fractions.
What it is
Retinalamin is the retina-tissue polypeptide fraction used in Russian ophthalmology series for retinal dystrophies and related recovery framing.
Linkova-school molecular writing pairs short peptides with neuronal and pigment-epithelium differentiation language also seen on the epitalon shelf.
We keep it as the flagship secondary eye fraction beside thinner labels such as normoftal.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Molecular retinoprotection frames
A CyberLeninka title on molecular mechanisms of retinoprotective action of short peptides sits beside broader bioregulatory peptides in ophthalmology reviews.
Glaucoma markers and desynchronosis
Titles cover neuronal markers in primary open-angle glaucoma, age-related desynchronosis in glaucoma patients, and secondary neuroprotection in glaucoma.
Research trail
Russian ophthalmology full text is the centre of gravity. PubMed rows, where mapped, are secondary English indexes of related series.
Military laser-exposure origin stories appear in corpus prose; classified trails are not treated as open evidence here.
Open limits
- Cataract-stasis mechanism attribution (lens versus inflammation) remains open.
- Circadian restoration language may mix pineal-axis and direct retinal frames.
- Tear-fluid marker changes need functional visual endpoint pairing in denser reading.
Russian full-text papers
- k voprosu o peptidnyh bioregulyatorah retinalamin obladaet kataraktostat Russian full text
- molekulyarnye mehanizmy retinoprotektornogo deystviya korotkih peptidov Russian full text
- lekarstvennye peptidnye preparaty proshloe nastoyaschee buduschee Russian full text
- neyronalnye markery pri pervichnoy otkrytougolnoy glaukome Russian full text
- vozrastnoy desinhronoz u patsientov s pervichnoy otkrytougolnoy glaukomo Russian full text
- bioregulyatornye peptidy v oftalmologii Russian full text
- vtorichnaya neyroprotektsiya pri glaukome Russian full text
- dinamika zritelnyh funktsiy v otdalennyy period pri ispolzovanii retinal Russian full text
- mnogoletniy opyt nizkodozirovannoy peptidnoy neyroprotektsii v meditsine Russian full text
9 in corpus
Also on PubMed
- 2024 [Objective structural and functional monitoring of polypeptide retinal neuroprotective therapy in diabetic retinopathy]. doi:10.17116/oftalma202414005197 PubMed
- 2021 [Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas]. doi:10.17116/oftalma202113705157 PubMed
- 2020 [Peptide bioregulators: delivery and efficacy]. doi:10.17116/oftalma202013602156 PubMed
- 2013 [Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results]. PubMed
- 2001 [Effectiveness of bio-regulators in the treatment of diabetic retinopathy]. PubMed
- 2003 Effects of peptides on proliferative activity of retinal and pigmented epithelial cells. doi:10.1023/a:1025497806636 PubMed
- 2002 Inductive activity of retinal peptides. doi:10.1023/a:1022654717358 PubMed
7 curated
Still open
- Which fraction peptides drive retinoprotection versus short AEDG neighbourhood effects?
- How reproducible are circadian IOP titles outside originating clinics?
- What open primary source exists for early military ophthalmology indications?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.